Capstone Investment Advisors »

Day One Biopharmaceuticals I shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.1M 236k 21.44
2025-09-30 $160k 23k 7.05
2023-09-30 $136k 11k 12.27

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr China Lg-cap Etf (FXI)
Alphabet Cap Stk Cl A (GOOGL)
Lumentum Hldgs Note 1.500%12/1 (Principal)
Meta Platforms Cl A (META)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Western Digital Corp Note 3.000%11/1 (Principal)

View all positions for Capstone Investment Advisors

Top funds holding Day One Biopharmaceuticals I

BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
FMR
Glazer Capital
State Street Corporation
Deerfield Management Company
Vanguard Capital Management
Balyasny Asset Management
CNH Partners
UBS Group
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
Bank of America Corporation

View all funds holding Day One Biopharmaceuticals I